Skip to main content
. 2022 Oct 6;9:1024790. doi: 10.3389/fcvm.2022.1024790

FIGURE 1.

FIGURE 1

Study cohort and analysis workflow. (A) The study comprised acute ischemic stroke patients with and without type 2 diabetes mellitus (SWDM; n = 92, SWoDM; n = 98). Patients were randomly divided into discovery and validation cohorts with comparable distribution of covariates (age, gender, diabetes and statin treatment). Statistically significant parameters (P < 0.05) between SWDM and SWoDM patients are marked with an asterisk (*). (B) Serum samples were collected within 24 h of clinical diagnosis of acute ischemic stroke from SWDM and SWoDM patients. Differentially regulated and statistically significant miRNAs detected in the discovery dataset generated from miRNA transcripts by RNA-Seq were investigated in the validation dataset. Combined analysis was then performed to identify FDR-significant miRNAs presented as validated differentially regulated miRNAs in SWDM compared to SWoDM patients.